Benznidazole
Benznidazole is a small molecule pharmaceutical. Benznidazole was first approved as Benznidazole on 2017-08-29. It is used to treat bacterial infections, chagas disease, and protozoan infections in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
---|---|
infections | D007239 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Benznidazole
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BENZNIDAZOLE | CHEMO Research | N-209570 RX | 2017-08-29 | 2 products, RLD, RS |
Labels
FDA
EMA
Brand Name | Status | Last Update |
---|---|---|
benznidazole | New Drug Application | 2021-01-12 |
Agency Specific
FDA
EMA
Expiration | Code | ||
---|---|---|---|
BENZNIDAZOLE, BENZNIDAZOLE, CHEMO RESEARCH SL | |||
2024-08-29 | ODE-154 |
Patent Expiration
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | BENZNIDAZOLE |
INN | benznidazole |
Description | Benznidazole is a monocarboxylic acid amide obtained by formal condensation of the carboxy group of (2-nitroimidazol-1-yl)acetic acid with the aromatic amino group of benzylamine. Used for treatment of Chagas disease. It has a role as an antiprotozoal drug. It is a member of imidazoles, a C-nitro compound and a monocarboxylic acid amide. |
Classification | Small molecule |
Drug class | antiprotozoal substances (metronidazole type) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | O=C(Cn1ccnc1[N+](=O)[O-])NCc1ccccc1 |
Identifiers
PDB | — |
CAS-ID | 22994-85-0 |
RxCUI | 18994 |
ChEMBL ID | CHEMBL110 |
ChEBI ID | — |
PubChem CID | 31593 |
DrugBank | DB11989 |
UNII ID | YC42NRJ1ZD (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 2,964 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
0 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more